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Abstract
Over the years, biological imaging has seen many advances,
allowing scientists to unfold many of the mysteries surround-
ing biological processes. The ideal imaging resolution would
be in nanometres, as most biological processes occur at this
scale. Nanotechnology has made this possible with functio-
nalised nanoparticles that can bind to specific targets and
trace processes at the cellular and molecular level. Quantum
dots (QDs) or semiconductor nanocrystals are luminescent
particles that have the potential to be the next generation
fluorophores. This paper is an overview of the basics of QDs
and their role as fluorescent probes for various biological
imaging applications. Their potential clinical applications
and the limitations that need to be overcome have also been
discussed.
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N
anotechnology is the manipulation of matter in
dimensions B100 nm. It is based on the fact
that the physical and chemical properties of
matter change considerably at the nanoscale compared
to those that they exhibit at the macroscale. Richard
Feynman’s famous talk ‘There is plenty of room at the
bottom’, which first introduced the concept of nanotech-
nology, was inspired by the complexity of biological
machinery, as most processes in living matter occur at the
nanoscale. Consider the size of a DNA molecule, which
approximates 2 nm, and the nuclear pores being  9n m
allow substances of less than this size to enter the nucleus.
It can therefore be assumed that nanoscience finds its
origin at the interface of the three basic sciences
of physics, chemistry and biology, leading to completely
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(page number not for citation purpose)new arenas of scientific discovery. The combination of
nanotechnology with biology is obvious as nanobiotech-
nology allows the use of nano-tools and nano-devices to
interact with, detect and alter biological processes at the
cellular and molecular level (1). The most important
application of nanobiotechnology is in nanomedicine,
which may be defined as the application of nanotechnol-
ogy to the diagnosis, monitoring and control of disease at
a molecular level using engineered nanoscale devices and
structures. Of the many nanoparticles that are currently
being investigated, semiconductor nanocrystals or quan-
tum dots (QDs) have a potential to lead to major
advancement in biological imaging as the next generation
fluorophores. This paper reviews the basics of QDs, the
process of biofunctionalisation along with their role as
fluorescent probes for in vitro and in vivo imaging. Their
potential clinical applications, limitations and future
perspectives are also discussed.
Historical background
Colloidal semiconductor QDs were first prepared by
Professor Louis Brus in 1982 (2) and this marked the
birth of a nanoscience building block (3). Their
photophysical properties have been explored in great
detail over the past two decades. Weller (4) first
described the quantum confinement effects of the
colloidal semiconductor Q-particles in 1993. In the
same year, Murray and colleagues (5) developed a
novel, reproducible method for the synthesis of high
quality, monodisperse nanocrystals. QDs were first
introduced to biological imaging in 1998 (6, 7) as
fluorophores with properties that give them tremendous
advantages over the traditional organic dyes (Table 1).
Since then, much progress has been made in exploring
their role in nanobiotechnology and nanomedicine as
tools for diagnostic and therapeutic applications.
Quantum dots (QDs)  basics
QDs are fluorescent semiconductor nanocrystals, com-
posed of materials from the elements in the periodic
groups of IIVI, IIIVo rI V VI, e.g. cadmium telluride
(Cd from group II and Te from group VI) and indium
phosphamide (In from group III and P from group V).
They range in size from 2 to 10 nm in diameter and
contain approximately 20010,000 atoms (8). Owing to
the effects of quantum confinement, QDs are highly
photostable, with broad absorption, narrow and sym-
metric emission spectra, slow excited-state decay rates
and broad absorption cross-sections. Their emission
colour depends on their size, chemical composition and
surface chemistry and can be tuned from the ultraviolet
to the visible and near-infrared (NIR) wavelengths.
Structure
The general structure of a QD (Fig. 1) comprises an
inorganic core semiconductor material, e.g. CdTe or
CdSe, and an inorganic shell of a different band gap
semiconductor material, e.g. ZnS. This is further coated
by an aqueous organic coating to which biomolecules can
be conjugated. Choice of the shell and coating is
important as the shell stabilises the nanocrystal core
and also alters the photophysical properties, while the
coating confers properties that allow its allocation to
various applications, such as determining solubility in
aqueous media, providing reactive groups for binding to
biological molecules as well as nullifying the toxicity.
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resulting in a very unstable structure that is prone to
photochemical degradation (9). Also, the core crystalline
structure has surface irregularities that lead to emission
irregularities like blinking. Capping the core with a
semiconductor material of a higher band gap, e.g. ZnS,
not only increases the stability and quantum yield (QY),
but also passivates the toxicity of the core by shielding
reactive Cd
2 and Te
2 ions from being exposed to
photo-oxidative environments, e.g. UV and air (9).
However, a ZnS coating is not sufficient to stabilise the
core in biological solutions and therefore a further
aqueous coating is required to ensure solubility in
biological media. QDs have been coated with a shell of
functionalised silica, phospholipid micelles, or linkers like
mercaptoacetic acid, mercaptoundecanoic acid, dihydro-
lipoic acid (DHLA), or amphiphyllic polymers like
modified polyacrylic acid, to render them soluble in
aqueous media (10). The aqueous coating can then
be tagged with various biomolecules of interest,
Core
 ZnS shell 
Biomolecules
 e.g. antibodies, 
peptides, etc. 
15–20 nm 
Surface
coating e.g. 
amphiphyllic
 polymer
Fig. 1. Structure of a quantum dot.
Table 1. Comparison between the optical properties of traditional organic dyes and QDs for biological application
Properties Organic dyes QDs Advantages of QD
Excitation spectrum Narrow Broad Organic dyes can only be excited by light of a specific wavelength due to the narrow
excitation spectrum vs QDs that may be excited by light of a range of wavelengths,
allowing multicolour QDs to be excited by a single wavelength of light.
Emission spectra Broad and
asymmetrical
Narrow and
symmetrical
The broad emission spectra of conventional dyes may overlap and this limits the
number of fluorescent probes that can be tagged to biomolecules for simultaneous
imaging in a single experiment. QDs have narrow emission spectra that can be
controlled by altering the size, composition and surface coatings of the dots. Hence,
multiple QDs emitting different colours can be excited by a single wavelength of light,
making them ideal for multiplexed imaging.
Photobleaching
threshold
Low High Organic dyes bleach within a few minutes on exposure to light whereas QDs are
extremely photostable due to their inorganic core, which is resistant to metabolic
degradation and can maintain high brightness even after undergoing repeated cycles
of excitation and fluorescence for hours. Hence, they can be used for long-term
monitoring and cell-tracking studies.
Decay lifetime Fast (B5 ns) Slow
(30100 ns)
The fluorescence lifetime of QDs is considerably longer than typical organic dyes
that decay within a few nanoseconds. This is valuable in overcoming the
autofluorescence of background tissues, hence improving signal to noise ratio.
Quantum yield
Absorbance cross
section
Saturation intensity
Low
Low
Low
High
High
High
QDs have higher quantum yields, a larger absorbance cross section and a larger
saturation intensity than organic fluorophores in aqueous environments, making
them much brighter probes for in vivo studies and continuous tracking experiments
over extended periods of time.
A review of the QDs and their applications for various biological imaging
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methods of bioconjugation have been described.
Mechanism of fluorescence
In the bulk form of the semiconductor material, the
electrons exist in a range of energy levels, described as
continuous. At the nanoscale, these levels become discrete
owing to the effects of quantum confinement. Following a
stimulus, the electron jumps from the valence to the
conduction band across the band gap, leaving behind a
positively charged hole. The coulomb correlated electron/
hole bound pair in a semiconductor material is called an
exciton and the quantum confinement effect occurs from
the physical confinement of the electrons in 3D (11). The
average physical distance between the electronhole pair is
the exciton bohr radius and this distance differs for the
different types of semiconductor materials. As the size of
the semiconductor material approaches the size of its
exciton bohr radius, its properties cease to resemble the
bulk material and the nanocrystal is called a QD. After
being excited to the conduction band, the valence electron
drops back to its valence position, emitting electromag-
netic radiation, which is different from the original
stimulus. This emission frequency is perceived as fluores-
cence and depends on the size of the band gap, which can
be altered by changing the size of the QD as well as
changing the surface chemistry. It is important to note
that the smaller the QD, the higher the band gap energy.
This size tunable absorption and emission property of
QDs is extremely valuable for biological imaging as they
can be tuned all the way from the UV to the NIR of the
spectrum such that smaller dots emit in the blue range
and larger dots in the red and NIR region (Fig. 2). QDs
have a broad excitation and narrow, discrete emission
spectra. The peak emission wavelength of the QD is
slightly longer than the first exciton peak or absorption
onset, and this energy separation is known as the Stoke’s
shift. Additionally, their peak emission wavelength is
independent of the wavelength of excitation light. This
means that variable-sized QDs can be excited by a single
wavelength of light, as long as this wavelength is shorter
than the absorption onset. This property finds applica-
tion in multiplexed imaging where a number of different-
sized QDs with discrete emission peaks and hence
different colours can be excited by a single wavelength
of light.
Process of biofunctionalisation
The synthesis of colloidal QDs and their application to
the biological scenario is a multistep process (Fig. 3).
Each step has its own challenges and involves
the integration of quantum physics, materials science,
synthetic chemistry and, most importantly, biology.
Synthesis
QDs can be synthesised by an organic or aqueous route
and, recently, a microwave-assisted method has also been
described. Currently, most available QDs have been
synthesised using the organic route involving high tem-
peratures and in the presence of surfactants to yield
monodisperse and stable particles (5, 12). However, the
QDs produced by the organic phase are insoluble in
aqueous media and therefore not applicable to biological
systems. A number of methods to solubilise organically
synthesised QDs in aqueous media have been developed
with good success and are described below. Aqueous
synthesis, on the other hand, produces water soluble QDs
through a simpler, inexpensive and reproducible method
that can easily be scaled up. However, aqueously synthe-
sised QDs do not have good crystallinity, have low QYs
andfullwidth half maximum (FWHM), andlongreaction
times, making preparation a time consuming and tedious
process (13). Recently, various groups have improved the
QY of water soluble QDs by optimising the synthetic
methods and post synthetic treatment, e.g. by illuminating
under room light for 20 days (13). Li and colleagues (14)
have recently described a new method of QD synthesis
based on microwave irradiation with controllable tem-
peratures. This allowed a rapid production of size tunable
QDs in 545 min, based on the reaction between Cd
2
and NaHTe solution (13). This method showedsignificant
advantages over the traditional aqueous synthesis, such as
reduced toxicity, good reproducibility, inexpensive, excel-
lent water solubility, stability and biological compatibility
and a comparable QY to the organic synthetic route.
Solubilisation
This is the biggest challenge prior to the biological
application of QDs. As most QDs are synthesised by
the organic route, their hydrophobic surface chemistry
makes them insoluble in aqueous biological media. Over
the years, scientists have discovered a wide array of
surface coatings for solubilisation of QDs (15). The aim is
to achieve an ideal surface chemistry that is stable in
biological media and does not alter the photophysical
properties of the QDs, while retaining a small size and
providing free reactive surface groups for binding and
recognition of biomolecules. The techniques used to
achieve solubilisation include ligand exchange, surface
silanisation and phase transfer methods. The ligand
exchange method is based on the exchange of the
hydrophobic surfactant molecules with bifunctional mo-
lecules, which are hydrophilic on one side and hydro-
phobic on the other, to bind to the ZnS shell on the QD
(16). Most often, thiols (SH) are used to bind to the ZnS
and carboxyl (COOH) groups are used as hydrophilic
ends. The resulting QDs are soluble in both aqueous and
polar solvents. This is by far the simplest method of
solubilisation. Surface silanisation involves the growth of
Sarwat B. Rizvi et al.
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highly cross linked, they are very stable. However, the
drawback is that the process is laborious and the shell
may be hydrolysed (6). The phase transfer method uses
amphiphyllic (17, 18) polymers to coat the QD surface.
The hydrophobic alkyl chains of the polymer interdigitate
with the alkyl groups on the QD surface, while the
hydrophilic groups point outwards to attain water
solubility. However, coating with a polymer may increase
the overall diameter of the QD and this may pose a
limitation in biological applications (19). Various reports
of coating using phospholipids micelles, dithioretol,
organic dendrons and oligomeric ligands are present in
the literature (2023).
Bioconjugation
Once solubilisation has been achieved, QDs can be
functionalised by conjugation to a number of biological
molecules, including avidin, biotin, oligonucleotides,
peptides, antibodies, DNA and albumin (16), through
surface reactive groups for specific targeted action.
Methods of bioconjugation broadly fall into two cate-
gories: non-covalent and covalent conjugation (24). Non-
covalent interactions include adsorption, electrostatic
Fig. 2. Size tunable emission.
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oligonucleotides and various serum albumins (25) can be
adsorbed on the surface of the water soluble QD. This
process is non-specific and depends on the pH, tempera-
ture, ionic strength and surface charge of the molecule
(16). QDs may be cationic or anionic and may interact
with biomolecules through electrostatic interaction. The
surface charge plays an important role in the cellular
interaction of QDs and is determined by the free surface
reactive groups. It has been demonstrated that proteins
engineered with positively charged domains can interact
with the negative charges on the QD surface coated with
DHLA through electrostatic interaction (26). These
conjugates have greater photoluminescence but are also
more stable than unconjugated dots. However, electro-
static interactions are non-specific and relatively weaker
compared to covalent bonding and this may pose a
problem in the biological environment. Many biological
molecules have a thiol group that can be tagged on to the
surface of a QD by a mercapto exchange process (16).
However, the resulting bond between thiol and Zn is not
only weak but also dynamic, and this may lead to
precipitation of the biomolecules in solution as they
easily detach from the QD surface. Covalent linkage is
the most stable of all the bioconjugation methods and
utilises functional groups on the QD surface, such as
primary amines, carboxylic acids, and thiols, to form a
covalent bond with similar groups present on the
biomolecules or through the use of crosslinker molecules
(16). The commonest method of bioconjugation is via the
avidinbiotin interaction. This is based on the high
affinity interaction between avidin and biotin through a
generic key-lock mechanism. Avidin is attached to
antibodies and biotin can be covalently bound to the
surface of QDs and vice versa. As most of the commer-
cially available biomolecules are avidin or biotin linked, it
makes this process most convenient as well (13, 26).
Bioimaging applications
Fluorescence microscopy is an established method of
visualising the structures and molecules within cells and
QDs are increasingly being used as fluorescent biological
labels for cellular and molecular imaging. QD application
to this field is similar to that of organic fluorophores but
with various advantages. They can be used to visualise
cellular structures and receptors in both fixed and live
cells. Although QDs have been used for a broad range of
biological applications (Fig. 4), their vast potential for
biomedical imaging and therapeutics remains unexplored.
In vitro imaging  fixed cells
QD conjugates can be used for several immunohisto-
chemical applications and have various advantages over
organic fluorophores, including increased photolumines-
cence, photostability, broad excitation and narrow emis-
sion spectra allowing multiplexed imaging. Mutlilabelling
QD protocols for an extremely sensitive immunohisto-
chemical detection have been described (27). Immuno-
histochemical detection of target molecules in fixed cells
involves the use of labelled primary antibodies that
specifically bind to the antigen of interest followed by
the application of a secondary antibody. Secondary
antibodies are conjugated to organic fluorophores or
enzymes that catalyse the deposition of fluorescent
substrates at or near the site of the primary antibody,
demonstrating that enzyme-based amplification can
greatly increase the sensitivity of immunohistochemical
detection (27).
Detection of target molecules in their natural distribu-
tion requires fixation followed by permeabilisation of the
cell wall by fluorescent probes. As QDs are larger than
organic dyes, they require different methods of cell
fixation and permeabilisation (28). The timing of cell
fixation, i.e. before or after exposure to QDs, determines
their stability, localisation within the cell as well as
emission properties. While in prefixed permeabilised cells,
QDs are readily internalised regardless of the cell type, in
live cells previously incubated with QDs, the choice of
fixative influences the fluorescence characteristics. A
comparative analysis of gluteraldehyde, methanol and
paraformaldehyde demonstrated that 2% paraformalde-
hyde was the fixative of choice (29).
QDAb conjugates have accurately identified mem-
brane-bound protein p-gp (glycoprotein) in fixed MCF7r
breast adenocarcinoma cells (13). The distribution of
p-gp was displayed by confocal reconstruction of 3D
imaging and this showed that QAb conjugate labelling
Synthesis 
organic 
aqueous 
Solubilisation 
ligand exchange 
silanisation 
Phase transfer method 
Biofunctionalisation 
covalent 
non-covalent 
 -Electrostatic 
 -Adsorption
Biological application 
Fig. 3. Pathway of processing quantum dots for biological
application.
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dyes like FITC, AlexaFluor488 and R-phycoerythrin.
Using QD conjugates, actin and microtubule fibres in the
cytoplasm (6) and various nuclear antigens of fixed
cancer cells have been stained (30). Indirect immuno-
fluorescence has been used to identify Her2, microtubules
and nuclear antigens in fixed cancer cells by first
incubating fixed cells with a primary Ab, then a
biotinylated secondary Ab and finally with QD-labelled
streptavidin. Apart from single-target labelling, double
labelling of nuclear antigens and Her2/microtubules with
two different QDs has also been demonstrated (Fig. 5).
The QDs were shown to be several fold more photostable
than the organic dye Alexafluor 488 (30).
Fluorescence in situ hybridisation (FISH) technology
to detect nucleic acid sequences in fixed biological
structures has been well established (31). It uses fluores-
cently labelled DNA probes for gene mapping and
identification of subtle chromosomal abnormalities and
can provide diagnostic and prognostic results for parti-
cular chromosomal disorders. It utilises the concept of
detection of a fluorescent signal at the site of hybridisa-
tion of a fluorescent dye-labelled probe with its homo-
logous chromosomal target. The drawbacks of using
rapidly photobeaching and multicolour organic dyes with
problems of spectral overlap can be overcome with
QDs with their high photostability and discrete spectra
allowing multiplexed imaging. Xiao and Barker (32) used
aQ D FISH probe to analyse human metaphase chromo-
somes (Fig. 6) and found that compared to organic dyes
like Texas-Red and FITC, QDs were more photostable
and significantly brighter, making them a more stable and
quantitative mode of FISH for research and clinical
applications. QDs are also likely to probe single DNA
molecules and their interaction with proteins, allowing
the study of dynamic processes. The application of QD
conjugates to visualise single-copy sequence DNA probes
as short as 1,500 nucleotides in length has been demon-
strated (33). This should find application in rapid gene
mapping and DNAprotein interactions (13).
In vitro imaging  live cells
One of the biggest challenges of cell biology is to explore
the molecular dynamics of various cellular events in live
cells. This would aid the understanding of cellular and
molecular interactions and monitor them over prolonged
periods at high resolution. QDs introduced to live cells
can be used for various applications like cell tracking,
which are crucial to stem cell research and determining
the metastatic potential of cancer cells. Their prolonged
photostability allows long-term imaging applications like
single-molecule tracking in living cells, hence unfolding
many cellular and molecular processes which have never
been done before.
Biological applications
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Fig. 4. Biological applications.
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various imaging applications. QDs can be loaded inside
the cells or be liganded to the extracellular surface.
Intracellular labelling could be achieved by incubating
cells with QDs via non-specific endocytosis (34, 35) or
they may be bound to peptides on the cell surface that are
specifically endocytosed (7). Alternatively, they can
be introduced into the cell via microinjection (20, 33,
36), which though laborious, is the only technique
that ensures uniform cytoplasmic distribution. By far,
Fig. 6. Detection of chromosome region 1q12 in human metaphase chromosomes by FISH using a QD-labelled probe. (A)
Control (no QD conjugate); (B) streptavidinQdot 605 detection of chromosome 1q12 region in homologous chromosomes
(vertical and horizontal arrows); bar in panel C is 10 mm. (32). Printed by permission of Oxford University Press.
Fig. 5. Fixed cell imaging and simultaneous detection of multiple cellular targets using QD conjugates. (A) Nuclear antigens in
the nuclei of human epithelial cells labelled with ANA, anti-human IgGbiotin and QD 630streptavidin. (B) When normal
human IgGs were used, no detectable stain was observed. (C) Simultaneous labelling of nuclear antigens (red) and microtubules
(green) using different QD conjugates in a 3T3 cell. (D) Her2 on the surface of SK-BR-3 cells was stained green with mouse
anti-Her2 antibody and QD 535IgG (green). Nuclear antigens were labelled with ANA, anti-human IgGbiotin and QD
630streptavidin (red). Reprinted with permission from Macmillan Publishers Ltd: Nature Biotechnology (30) copyright 2003.
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most commonly used. This approach is based on the fact
that protein transduction domains (PTD) can allow the
passive delivery of drugs across the cell membranes as
well as the blood brain barrier. A number of biomole-
cules, including proteins, oligonucleotides, liposomes and
magnetic nanoparticles, have been delivered into cells
using PTDs (37). It has been shown that QDs can be
delivered into cells using similar techniques. QDs have
been coupled to PTDs via a streptavidinbiotin link (38),
covalently (39), by electrostatic adsorption or adsorption
to synthetic PTDs like pep-1 (40). Of all the approaches
for intracellular delivery, coupling PTDs to QDs via a
streptavidinbiotin is most easily performed.
Extracellular labelling via membrane receptors and
membrane-associated proteins are good targets for QD
imaging. Various biological processes and pathways, such
as chemotaxis, synaptic regulation or signal transduction,
rely on the transmembrane receptors and signalling
pathways. Plasma membranes have a complex and
dynamic architecture with various components that affect
the diffusion of endogenous proteins and lipids. Pinaud
et al. (41) used biotinylated peptide-coated QDs to study
the organisation of the plasma membrane and the
influence of lipid raft microdomains on the diffusion of
raft-associated proteins in HeLa cells. Labelling with
QDs allowed high-resolution and long-term tracking of
an individual glycosyl-phosphatidyl-inositol-anchored
avidin test probe (Av-GPI), and the classification of their
various diffusive behaviours.
Single-particle tracking
This is a technique of following single molecules in real
time to visualise the actual molecular dynamics in their
habitat environment. This can be used to track various
biological molecules like lipids, membrane-associated
proteins and cytosolic motor proteins, as well as detailed
descriptions of the compartment sizes of micro-domains
and the time that individual macromolecules reside in
each compartment. Apart from genetically encoded
fluorescent proteins and organic dyes, various materials
have been used for single-particle tracking studies,
including latex or fluorescent microspheres ( 20500
nm) and colloidal gold nanoparticles (40 nm). Fluores-
cent proteins and organic dyes have low photolumines-
cence in a background of high cell autofluorescence and a
low photobleaching threshold making long-term tracking
difficult. Gold nanoparticles are good agents for single-
particle tracking, but do not allow multiplexed imaging.
QD probes have been used to demonstrate the
dynamics of glycine receptors (GlyRs) in neuronal
membranes (42). QDs were used to track indivi-
dual GlyRs and analyse their lateral dynamics in
neuronal membranes in living cells over periods of time
ranging from milliseconds to minutes. QD labelling
enabled imaging for 20 min as compared to the organic
dye Cy3, which allowed imaging for only 5 sec. Tracking
individual dots allowed characterisation of multiple
diffusion domains showing that QDs are ideal probes
for single-molecule studies in live cells. Using single-QD
tracking, the dynamics of individual GABA receptors in
the axonal growth of spinal neurons has also been
demonstrated (43). Biotinylated epidermal growth factor
(EGF)-conjugated QDs have been used to study the
endocytosis and trafficking of erbB receptors, showing a
previously unreported mechanism of retrograde transport
to the cell body (44).
Stem cell tracking
As one of the most fascinating areas of contemporary
biology, stem cell research has a vast potential to treat a
myriad of medical conditions. Currently, magnetic and
superparamagnetic iron oxide (SPIO) nanoparticles are
being used to achieve this objective through the use of
MRI. However, the gradual loss of the MRI cell signal
due to cell division poses a hindrance to long-term
imaging studies. The application of QDs as nanomaterials
for monitoring stem cell survival, distribution, differentia-
tion and regenerative impact either in vitro or in vivo due
to their inherent long-term fluorescence intensity has been
shown by several groups. Shah et al. (45) reported the
long-term labelling of human bone marrow-derived
mesenchymal stem cells (hMSC) with RGD peptide-
conjugated QDs during self-replication and differentia-
tion in osteogenic cell lineages. The same group also
demonstrated that RGD-conjugated QD-labelled hMSCs
remained viable following multilineage differentiation as
did the unlabelled hMSCs (46). The regenerative potential
of stem cells to repair damaged cardiac tissue is being
investigated, but attempts at tracking the differentiation
and distribution of stem cells in vivo have been hampered
by the inherent autofluorescence of damaged cardiac
tissue. QD-labelled hMSC can illuminate stem cells in
histological sections for at least 8 weeks following delivery,
allowing a 3D reconstruction of the location of all stem
cells following injection into the heart (47). While QD-
labelled tracking of stem cells promises great advance-
ments in the field of stem cell research, the effects of QDs
on stem cell self-renewal and differentiation are largely
unknown and need to be explored.
Phagokinetic assays
QDs have been used to demonstrate the metastatic
potential of cancer cells to distinguish between invasive
and non-invasive cancer cell lines (48). Gu et al. (49, 50)
have demonstrated a 2D in vitro cell motility assay based
on the phagokinetic uptake of QDs by cells as they move
across a homogenous layer of QDs, leaving behind a
fluorescent free trail. The ratio of the trail area to the cell
A review of the QDs and their applications for various biological imaging
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tumour cells (49, 50).
Biosensing applications
Fluorescence resonance energy transfer (FRET) is a
process in which energy is transferred from an excited
donor to an acceptor particle, leading to a reduction in
the donor’s emission and excited-state lifetime and an
increase in the acceptor’s emission intensity. This happens
whenever the distance between the donor and acceptor is
smaller than the critical radius, known as the Fo ¨rster
radius (9). FRET is sensitive to the distance between the
donor and the acceptor and is used to measure changes in
distances rather than absolute distances. It is therefore
suitable for studying biomolecule conformation, dy-
namics and interactions, e.g. monitoring protein confor-
mational changes, protein interactions and assaying
enzyme activity (9). Using organic dyes for FRET poses
the problems of early photobleaching and significant
emission overlap between the donor and acceptor and
QDs provide an excellent alternative.
QD-based FRET technology has found application in
monitoring other processes, such as DNA replication and
telomerisation, for fast and sensitive DNA detection and
DNA array analyses (51). Most QD-based FRET probes
are based on QDs as donors and organic fluorophores as
acceptors. A single QD-based nanosensor capable of
detecting extremely low concentrations of DNA (50
copies) in a separation-free format has been demon-
strated (52). QDs were linked to DNA probes to capture
DNA targets. The target strand binds to a dye-labelled
reporter strand, thus forming a FRET donor-acceptor
ensemble.
QD FRET-based sensing can also be used to detect
receptor-ligand binding. QDs conjugated to maltose-
binding protein (MBP) were used to demonstrate the
association of maltose with MBP by a competitive
binding mechanism that induced a FRET change and
was hence able to detect the presence of maltose in
solution (53). QD-linked MBP interacted with QSY-9
(organic dye) conjugate in the absence of maltose,
resulting in quenching of fluorescence of the QDs by
the dye. Adding maltose displaced the dye and restored
QD fluorescence. Another application of QD-FRET is
the detection of enzyme activity in particular protease
sensing. This is based on inserting peptide sequences of
various proteases between QDs and quenchers (or
acceptor dyes). The QD fluorescence is quenched by the
acceptor dye, but cleavage of the peptide sequences by
specific proteases causes removal of these acceptor
molecules, and hence the QDs are switched on. A good
example is rhodamine Red-X dye-labelled peptides linked
to CdSe/ZnS QDs used as FRET probes to monitor the
proteolytic ability of collagenases in normal and cancer
cells. Hydrolytic cleavage of the peptide-linked dye by the
collagenases restored QD fluorescence allowing detection
of specific enzyme activity over short periods of time (54).
Bioluminescence resonance energy transfer (BRET) is
a naturally occurring phenomenon, whereby a light-
emitting protein that acts as a donor (e.g. Renilla
luciferase) non-radiatively transfers energy to a fluores-
cent protein as an acceptor (e.g. GFP) in close proximity.
The process is similar to FRET except that the energy
comes from a chemical reaction catalysed by the donor
enzyme (e.g. Renilla luciferase-mediated oxidation of its
substrate coelenterazine) rather than absorption of ex-
citation photons. So et al. (55) prepared self-illuminating
QDs by covalently coupling QDs (as acceptors) to a
bioluminescent protein Renilla reniformis luciferase (as a
donor). The protein emits a blue light at 480 nm on
addition of a substrate, coelenterazine. The QDs can be
excited if they are in close proximity to the protein and
emit at their emission maxima. These conjugates emit
long-wavelength (from red to NIR) bioluminescent light
in cells and in animals, even in deep tissues, and are
suitable for multiplexed in vivo imaging.
In vivo imaging
Fluorescence imaging of live animals is limited by the
poor transmission of visible light through the living
tissues as well as by the intense autofluorescence of tissue
chromophores. QDs can overcome these limitations
through their high photoluminescence, enhanced photo-
stability under prolonged laser illumination and size
tunability to emit at longer wavelengths like the NIR,
which is not subjected to scattering and absorption as
light in the visible range. Also, QDs have a two-photon
absorption cross section severaltimes greater than organic
dyes and this property makes them more efficient at
probing thick tissue specimens by multiphoton micro-
scopy (56). Green-emitting QDs were injected in living
mice intravenously and dynamically visualised by two-
photon microscopy as they perfused through the skin
capillaries several micrometers deep. Two-photon excita-
tion allows greater tissue penetration due to excitation in
theNIR range (56).Vouraet al. (57)used spectral imaging
to trace intravenously injected tumour cells labelled with
QDs into mice as they extravastated into lung tissue, and
found that the behaviour of QD-labelled tumour cells in
vivo was indistinguishable from that of unlabelled cells.
Also QDs and spectral imaging allowed the simultaneous
identification offive different populations of cells using an
interesting multiphoton laser excitation application (57).
Sentinel lymph node biopsy (SLNB)
This is a means of ultra-staging cancer metastasis and is
now the standard of care in breast cancer surgery. It is
based on targeting the first draining lymph node, also
called the sentinel lymph node (SLN) of a lymphatic
basin at the cancer site to determine the extent of disease
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disease is limited and extensive surgery can be avoided.
Current tracers for SLN biopsy include the blue dye and
radio-isotope. However, these have various limitations
that can be overcome by the use of QDs that emit in the
NIR range ( 700 nm). The main problem with
live animal imaging is to overcome the background tissue
autofluorescence. NIR imaging can overcome this
problem based on the concept that normal tissue
chromophores do not absorb or scatter light in the
NIR range. NIR light can therefore penetrate deeper
tissues without being scattered and is ideal for imaging in
real time. NIR QDs have successfully been used to
demonstrate in vivo SLN biopsy in mice and pigs (21)
(Fig. 7). An intradermal injection of picomolar quantities
of NIR QDs entered the lymphatics and the fluorescence
could be traced to the SLN in real time by the surgeon
using an NIR imaging system. This allowed an accurate
and sensitive localisation and biopsy of the SLN with
minimal tissue dissection.
Fig. 8 is a schematic diagram of an NIR imaging system
for SLNB in breast cancer surgery, as this has potential to
be one of the major clinical applications of QDs in the
future. The NIR light penetrates deep tissues with
minimal scatter and excites the QDs that emit in the
NIR range. The fluorescence from these dots is detected
by an NIR camera, which is basically a regular CCD
camera without an infrared (IR) filter. These images can
be superimposedwith images from the colourcamera on a
PC to anatomically locate the exact position of the QDs.
Cancer localisation and therapy
In vivo localisation of cancer antigens using QDs bound to
tumour-specific antibodies has been demonstrated in
molecular imaging studies. Antibody specific to prostate
cancer cell marker PSMA was conjugated to QDs and
injected into mice transplanted with human prostate
cancer. This accurately localised the tumour, which was
clearly imaged in vivo. Their bright luminescence and long
lifetime allowed a more accurate and sensitive imaging
compared to green fluorescent protein (GFP) (38). QDs
linked to alpha-fetoprotein (AFP) monoclonal antibody
were injected intravenously and successfully targeted
human hepatocellular carcinoma xenograft growing in
Fig. 8. Schematic diagram of a near-infrared imaging system for SLNB in breast cancer surgery.
Fig. 7. Detection of sentinel lymph node using NIR QDs in
a mouse model. NIR QDs injected intradermally into the
foot pad of a mouse migrate to the sentinel lymph node
5 min post injection. (A) Colour video image; (B) NIR
ﬂuorescence image; isosulphan blue dye colocalised to the
same node (indicated by the arrows). Reprinted by permis-
sion from Macmillan Publishers Ltd: Nature Biotechnology
(21), copyright 2004.
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were able to detect increased expression of EGFR levels,
which corresponds to early change from cervical dysplasia
to cancer (59). This can have a huge impact on the early
diagnosis and treatment of cancer.
Other applications
Drug delivery
Targeted QD imaging may find application as an ultra-
sensitive tool for early cancer diagnosis as well as image-
guided drug delivery of chemotherapeutic agents to
overcome systemic side effects. Drugs can be targeted to
tumours by an enhanced permeability and retention
(EPR) effect and this concept has been applied to
anticancer agents (10). QD probes can target and
accumulate in tumours by both the EPR effect and
recognition of cancer cell surface biomarkers. Che-
motherapeutic agents bound to QD probes that will
recognise and bind to cancer cells, might offer a new
strategy for molecular cancer therapy by avoiding sys-
temic toxicity. QDs are one of the many nanoscale
platforms being developed as novel drug delivery systems
(60) based on their ability to target specific sites at a
molecular level and unique photophysical properties (61).
Photodynamic therapy (PDT)
One of the major advances in minimally invasive
therapies for cancer is photodynamic therapy (PDT).
First discovered in the early 1900s, it is now an approved
cancer treatment for various superficial malignancies,
including basal cell carcinoma, oral, oesophageal and
lung cancers (62). It is based on the targeted localised
destruction of diseased tissues via the generation of
cytotoxic singlet oxygen (
1O2) using a non-toxic photo-
sensitiser (PS), activated by light of a specific wavelength
in the presence of molecular oxygen (
3O2). Singlet oxygen
leads to cellular necrosis and apoptosis of target cells via
oxidation and degradation of cellular components.
Photofrin is the most commonly used PS for PDT and
suffers from various drawbacks like instability in aqueous
solution, prolonged cutaneous sensitivity, chemical im-
purities and weak absorption at therapeutic wavelengths
essential for deep tissue penetration (63, 64). The
application of QDsPS complexes as therapeutic PDT
agents was first reported by Samia et al. (65). QDs can be
used in PDT either indirectly as energy donors to
conventional PSs by FRET mechanism or directly as
they react with molecular oxygen by energy transfer
mechanisms to generate reactive oxygen species (ROS)
(Fig. 9). With their high photoluminescence quantum
efficiency, prolonged photostability, high molar extinc-
tion coefficients and tunable emission spectra at NIR
wavelengths, they form ideal donors for the FRET
process (66) in PDT. Also, functionalisation of the QD
surface gives the advantage of enhanced solubility,
biocompatibility and localisation of the QDPS pair to
the exact cancer site for specific targeted action (66).
Donor Acceptor 
QD 
FRET
Förster radius 
(Distance between donor and 
acceptor)  
3O2
(Triplet state) 
1O2
(Singlet state) 
Free
radicals 
Destruction of 
cancer cells  
PS 
Light activation 
of the
QD-PS
FRET pair in the 
presence of 3O2 
3O2
Fig. 9. Mechanism of PDT using quantum dots. QD-PS FRET pair localises to the site of cancer and is activated by light of a
speciﬁc wavelength in the presence of molecular oxygen (
3O2) to generate singlet oxygen, which is toxic to cancer cells. Free
radicals are also generated directly by activation of the QD by light.
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Using the concept of multiplexed imaging, different food-
borne pathogenic bacteria have been simultaneously
detected at low concentrations of 10
3 cfu/ml within
2 h by using antibody-conjugated QDs and magnetic
microparticles (67). When compared with organic green
dye fluorescein isothiocyanate, CdSe/ZnS core/shell bio-
conjugates displayed brighter fluorescence intensities,
lower detection thresholds and better accuracy in analys-
ing bacterial cell mixtures composed of pathogenic
Escherichia coli O157:H7 and harmless E. coli DH5alpha
using flow cytometry. A novel method for an ultrasensi-
tive, fluorescent detection of DNA and antigen molecules
based on self-assembly of multiwalled carbon nanotubes
and CdSe QDs via oligonucleotide hybridisation has also
been described (68). Overall, the QD technology demon-
strates great potential for a rapid and cost-effective
detection of pathogen and toxin contamination of food
samples.
Limitations
Introduction of QDs to the biological milieu involves
elaboration of various aspects, such as toxicity, throm-
bogenicity, immunogenicity as well as ADME character-
istics (absorption, metabolism, distribution and
excretion). QD toxicity can arise from different levels,
including composition of the core, surface coating, size
and surface charge (6971). The core nanocrystal is
composed of heavy metals like cadmium, tellurium and
selenium, which are known to have acute and chronic
toxicities. Characterisation of in vitro and in vivo toxicity
of QDs has been a daunting task due to the complex
nature of these nanomaterials. Over the years, a number
of studies have emerged with conflicting results, which
makes it difficult to evaluate, generalise and predict the
important aspects of toxicity. Most research is based on
in vitro cytotoxicity, which involves exposure to very high
doses. Fewer in vivo studies looking at ADME character-
istics in small animals have been published. As the in vivo
toxicity of QDs evolves from changes induced at the
molecular level, it is crucial to first characterise
the cellular interaction in relation to various representa-
tive cell lines. Little is known about the mechanism of QD
uptake by cells and its interaction with the different
cellular organelles. It is therefore critical to understand
and explore these mechanisms for progress in the field of
nanomedicine, cancer diagnosis and treatment.
Other limitations to the QD application are based on
photophysical properties like blinking and photobrigh-
tening. Blinking occurs when the QD rapidly alternates
between an emitting and non-emitting state. This may
cause problems in single-molecule imaging or tracking.
Photobrightening on the other hand, is the increase in the
intensity of fluorescence of the QD on excitation.
Although this may be advantageous, in certain cases it
poses a problem in fluorescence quantisation studies (16).
Both blinking and photobrightening result from
the mobile charges present on the surface of the QDs.
A significant amount of research is underway to evaluate
and overcome these limitations (56, 72, 73).
Future perspectives
QDs have found vast application in biological and
biomedical research as the next generation fluorescent
probes. They are a powerful tool for illuminating many of
the mysteries that encompass signal transduction path-
ways and biomolecular interaction within cells. Through
extrapolating their properties for in vivo molecular and
cellular imaging, QDs have a potential to lead to major
advances in nanomedicine. They can revolutionise cancer
diagnosis and therapy through early pre-symptomatic
diagnosis and image-guided drug delivery of chemother-
apeutic agents. NIR QDs may replace the current tracers
for SLN biopsy. The most promising aspect of QD
application is in their use as PSs for PDT. This applica-
tion is unique as it utilises their inherent toxicity via the
generation of ROS to target cancer cells and micro-
organisms. Overall, there are relentless possibilities for
the application of QDs in biology and nanomedicine.
However, QD technology is still in its infancy and
extensive research is still required to resolve many of
the issues that are limiting their safe application in
clinical medicine.
Acknowledgements
We would like to acknowledge the ﬁnancial support of The Sebba
Trust, UK, for development of QDs for detection of breast cancer.
References
1. West JL, Halas NJ. Applications of nanotechnology to biotech-
nology commentary. Curr Opin Biotechnol 2000; 11: 2157.
2. Rossetti R, Brus L. Electron-hole recombination emission as a
probe of surface-chemistry in aqueous CdS colloids. J Phys
Chem 1982; 86: 44702.
3. Alivisatos AP. Birth of a nanoscience building block. ACS Nano
2008; 2: 15146.
4. Weller H. Colloidal semiconductor Q-particles  chemistry in
the transition region between solid-state and molecules. Angew
Chem Int Ed Eng 1993; 32: 4153.
5. Murray CB, Norris DJ, Bawendi MG. Synthesis and character-
ization of nearly monodisperse Cde (eS, Se, Te) semiconduc-
tor nanocrystallites. J Am Chem Soc 1993; 115: 870615.
6. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP.
Semiconductor nanocrystals as ﬂuorescent biological labels.
Science 1998; 281: 20136.
7. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive
nonisotopic detection. Science 1998; 281: 20168.
8. Smith AM, Duan H, Mohs AM, Nie S. Bioconjugated quantum
dots for in vivo molecular and cellular imaging. Adv Drug Deliv
Rev 2008; 60: 122640.
A review of the QDs and their applications for various biological imaging
Citation: Nano Reviews 2010, 1: 5161 - DOI: 10.3402/nano.v1i0.5161 13
(page number not for citation purpose)9. Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M,
Seifalian AM. Biological applications of quantum dots. Bioma-
terials 2007; 28: 471732.
10. Iga AM, Robertson JH, Winslet MC, Seifalian AM. Clinical
potential of quantum dots. J Biomed Biotechnol 2007; 2007:
76087.
11. Arya H, Kaul Z, Wadhwa R, Taira K, Hirano T, Kaul SC.
Quantum dots in bio-imaging: revolution by the small. Biochem
Biophys Res Commun 2005; 329: 11737.
12. Peng ZA, Peng X. Formation of high-quality CdTe, CdSe, and
CdS nanocrystals using CdO as precursor. J Am Chem Soc
2001; 123: 1834.
13. Weng J, Ren J. Luminescent quantum dots: avery attractive and
promising tool in biomedicine. Curr Med Chem 2006; 13:
897909.
14. Li L, Qian H, Ren J. Rapid synthesis of highly luminescent
CdTe nanocrystals in the aqueous phase by microwave irradia-
tion with controllable temperature. Chem Commun (Camb)
2005; 4: 52830.
15. Pinaud F, Michalet X, Bentolila LA, Tsay JM, Doose S, Li JJ,
et al. Advances in ﬂuorescence imaging with quantum dot bio-
probes. Biomaterials 2006; 27: 167987.
16. Alivisatos AP, Gu W, Larabell C. Quantum dots as cellular
probes. Annu Rev Biomed Eng 2005; 7: 5576.
17. Wang XS, Dykstra TE, Salvador MR, Manners I, Scholes GD,
Winnik MA. Surface passivation of luminescent colloidal
quantum dots with poly(dimethylaminoethyl methacrylate)
through a ligand exchange process. J Am Chem Soc 2004;
126: 77845.
18. Nann T. Phase-transfer of CdSe@ZnS quantum dots using
amphiphilic hyperbranched polyethylenimine. Chem Commun
(Camb) 2005; 13: 17356.
19. Uyeda HT, Medintz IL, Jaiswal JK, Simon SM, Mattoussi H.
Synthesis of compact multidentate ligands to prepare stable
hydrophilic quantum dot ﬂuorophores. J Am Chem Soc 2005;
127: 38708.
20. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou
AH, Libchaber A. In vivo imaging of quantum dots encapsu-
lated in phospholipid micelles. Science 2002; 298: 175962.
21. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama
A, et al. Near-infrared ﬂuorescent type II quantum dots for
sentinel lymph node mapping. Nat Biotechnol 2004; 22: 937.
22. Pathak S, Choi SK, Arnheim N, Thompson ME. Hydroxylated
quantum dots as luminescent probes for in situ hybridization.
J Am Chem Soc 2001; 123: 41034.
23. Wang YA, Li JJ, Chen H, Peng X. Stabilization of inorganic
nanocrystals by organic dendrons. J Am Chem Soc 2002; 124:
22938.
24. Xing Y, Xia Z, Rao J. Semiconductor quantum dots for
biosensing and in vivo imaging. IEEE Trans Nanobiosci 2009;
8: 412.
25. Lakowicz JR, Gryczynski I, Gryczynski Z, Nowaczyk K,
Murphy CJ. Time-resolved spectral observations of cadmium-
enriched cadmium sulﬁde nanoparticles and the effects of DNA
oligomer binding. Anal Biochem 2000; 280: 12836.
26. Clapp AR, Goldman ER, Mattoussi H. Capping of CdSeZnS
quantum dots with DHLA and subsequent conjugation with
proteins. Nat Protoc 2006; 1: 125866.
27. Akhtar RS, Latham CB, Siniscalco D, Fuccio C, Roth KA.
Immunohistochemical detection with quantum dots. Methods
Mol Biol 2007; 374: 1128.
28. Ornberg RL, Liu H. Immunoﬂuorescent labeling of proteins in
cultured cells with quantum dot secondary antibody conjugates.
Methods Mol Biol 2007; 374: 310.
29. Williams Y, Byrne S, Bashir M, Davies A, Whelan A, Gun’ko Y,
et al. Comparison of three cell ﬁxation methods for high content
analysis assays utilizing quantum dots. J Microsc 2008; 232:
918.
30. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, et al.
Immunoﬂuorescent labeling of cancer marker Her2 and other
cellular targets with semiconductor quantum dots. Nat Biotech-
nol 2003; 21: 416.
31. Levsky JM, Singer RH. Fluorescence in situ hybridization: past,
present and future. J Cell Sci 2003; 116: 28338.
32. Xiao Y, Barker PE. Semiconductor nanocrystal probes for
human metaphase chromosomes. Nucleic Acids Res 2004; 32:
e28.
33. Knoll JH. Human metaphase chromosome FISH using quan-
tum dot conjugates. Methods Mol Biol 2007; 374: 5566.
34. Hoshino A, Hanaki K, Suzuki K, Yamamoto K. Applications
of T-lymphoma labeled with ﬂuorescent quantum dots to cell
tracing markers in mouse body. Biochem Biophys Res Commun
2004; 314: 4653.
35. Hanaki K, Momo A, Oku T, Komoto A, Maenosono S,
Yamaguchi Y, et al. Semiconductor quantum dot/albumin
complex is a long-life and highly photostable endosome marker.
Biochem Biophys Res Commun 2003; 302: 496501.
36. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. Long-term
multiple color imaging of live cells using quantum dot biocon-
jugates. Nat Biotechnol 2003; 21: 4751.
37. Lagerholm BC. Peptide-mediated intracellular delivery of quan-
tum dots. Methods Mol Biol 2007; 374: 10512.
38. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer
targeting and imaging with semiconductor quantum dots. Nat
Biotechnol 2004; 22: 96976.
39. Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M,
Yamaguchi Y, et al. Quantum dots targeted to the assigned
organelle in living cells. Microbiol Immunol 2004; 48: 98594.
40. Mattheakis LC, Dias JM, Choi YJ, Gong J, Bruchez MP, Liu J,
et al. Optical coding of mammalian cells using semiconductor
quantum dots. Anal Biochem 2004; 327: 2008.
41. Pinaud F, Michalet X, Iyer G, Margeat E, Moore HP, Weiss S.
Dynamic partitioning of a glycosyl-phosphatidylinositol-an-
chored protein in glycosphingolipid-rich microdomains imaged
by single-quantum dot tracking. Trafﬁc 2009; 10: 691712.
42. Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B, Triller A.
Diffusion dynamics of glycine receptors revealed by single-
quantum dot tracking. Science 2003; 302: 4425.
43. Bouzigues C, Levi S, Triller A, Dahan M. Single quantum dot
tracking of membrane receptors. Methods Mol Biol 2007; 374:
8191.
44. Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post JN,
Grecco HE, et al. Quantum dot ligands provide new insights
into erbB/HER receptor-mediated signal transduction. Nat
Biotechnol 2004; 22: 198203.
45. Shah B, Clark P, Stroscio M, Mao J. Labeling and imaging of
human mesenchymal stem cells with quantum dot bioconjugates
during proliferation and osteogenic differentiation in long term.
Conf Proc IEEE Eng Med Biol Soc 2006; 1: 14703.
46. Shah BS, Clark PA, Moioli EK, Stroscio MA, Mao JJ. Labeling
of mesenchymal stem cells by bioconjugated quantum dots.
Nano Lett 2007; 7: 30719.
47. Rosen AB, Kelly DJ, Schuldt AJ, Lu J, Potapova IA, Doronin
SV, et al. Finding ﬂuorescent needles in the cardiac haystack:
tracking human mesenchymal stem cells labeled with quantum
dots for quantitative in vivo three-dimensional ﬂuorescence
analysis. Stem Cells 2007; 25: 212838.
Sarwat B. Rizvi et al.
14
(page number not for citation purpose)
Citation: Nano Reviews 2010, 1: 5161 - DOI: 10.3402/nano.v1i0.516148. Pellegrino T, Parak WJ, Boudreau R, Le Gros MA, Gerion D,
Alivisatos AP, et al. Quantum dot-based cell motility assay.
Differentiation 2003; 71: 5428.
49. Gu W, Pellegrino T, Parak WJ, Boudreau R, Le Gros MA,
Alivisatos AP, et al. Measuring cell motility using quantum dot
probes. Methods Mol Biol 2007; 374: 12531.
50. Gu W, Pellegrino T, Parak WJ, Boudreau R, Le Gros MA,
Gerion D, et al. Quantum-dot-based cell motility assay. Sci
STKE 2005; 2005: 15.
51. Patolsky F, Gill R, Weizmann Y, Mokari T, Banin U, Willner I.
Lighting-up the dynamics of telomerization and DNA replica-
tion by CdSeZnS quantum dots. J Am Chem Soc 2003; 125:
139189.
52. Zhang CY, Yeh HC, Kuroki MT, Wang TH. Single-quantum-
dot-based DNA nanosensor. Nat Mater 2005; 4: 82631.
53. Medintz IL, Clapp AR, Mattoussi H, Goldman ER, Fisher B,
Mauro JM. Self-assembled nanoscale biosensors based on
quantum dot FRET donors. Nat Mater 2003; 2: 6308.
54. Shi L, De Paoli V, Rosenzweig N, Rosenzweig Z. Synthesis and
application of quantum dots FRET-based protease sensors. J
Am Chem Soc 2006; 128: 103789.
55. So MK, Xu C, Loening AM, Gambhir SS, Rao J. Self-
illuminating quantum dot conjugates for in vivo imaging. Nat
Biotechnol 2006; 24: 33943.
56. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP,
Wise FW, et al. Water-soluble quantum dots for multiphoton
ﬂuorescence imaging in vivo. Science 2003; 300: 14346.
57. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. Tracking
metastatic tumor cell extravasation with quantum dot nano-
crystals and ﬂuorescence emission-scanning microscopy. Nat
Med 2004; 10: 9938.
58. Chen LD, Liu J, Yu XF, He M, Pei XF, Tang ZY, et al. The
biocompatibility of quantum dot probes used for the targeted
imaging of hepatocellular carcinoma metastasis. Biomaterials
2008; 29: 41706.
59. Nida DL, Rahman MS, Carlson KD, Richards-Kortum R,
Follen M. Fluorescent nanocrystals for use in early cervical
cancer detection. Gynecol Oncol 2005; 99: S89S94:
60. Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG,
Grobmyer SR. Emerging implications of nanotechnology on
cancer diagnostics and therapeutics. Cancer 2006; 107: 45966.
61. Hild WA, Breunig M, Goepferich A. Quantum dots  nano-
sized probes for the exploration of cellular and intracellular
targeting. Eur J Pharm Biopharm 2008; 68: 15368.
62. Hopper C. Photodynamic therapy: a clinical reality in the
treatment of cancer. Lancet Oncol 2000; 1: 2129.
63. Pandey RK. Recent advances in photodynamic therapy.
J Porphyr Phthalocya 2000; 4: 36873.
64. Samia AC, Dayal S, Burda C. Quantum dot-based energy
transfer: perspectives and potential for applications in photo-
dynamic therapy. Photochem Photobiol 2006; 82: 61725.
65. Samia AC, Chen X, Burda C. Semiconductor quantum dots for
photodynamic therapy. J Am Chem Soc 2003; 125: 157367.
66. Yaghini E, Seifalian AM, MacRobert AJ. Quantum dots and
their potential biomedical applications in photosensitization for
photodynamic therapy. Nanomedicine (Lond) 2009; 4: 35363.
67. Zhao Y, Ye M, Chao Q, Jia N, Ge Y, Shen H. Simultaneous
detection of multifood-borne pathogenic bacteria based on
functionalized quantum dots coupled with immunomagnetic
separation in food samples. J Agric Food Chem 2009; 57:
51724.
68. Cui D, Pan B, Zhang H, Gao F, Wu R, Wang J, et al. Self-
assembly of quantum dots and carbon nanotubes for
ultrasensitive DNA and antigen detection. Anal Chem 2008;
80: 79968001.
69. Kirchner C, Liedl T, Kudera S, Pellegrino T, Munoz JA, Gaub
HE, et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS
nanoparticles. Nano Lett 2005; 5: 3318.
70. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger
D. Differences in subcellular distribution and toxicity of green
and red emitting CdTe quantum dots. J Mol Med 2005; 83:
37785.
71. Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K.
On the cyto-toxicity caused by quantum dots. Microbiol
Immunol 2004; 48: 66975.
72. Hohng S, Ha T. Near-complete suppression of quantum dot
blinking in ambient conditions. J Am Chem Soc 2004; 126:
13245.
73. Yao J, Larson DR, Vishwasrao HD, Zipfel WR, Webb WW.
Blinking and nonradiant dark fraction of water-soluble quan-
tum dots in aqueous solution. Proc Natl Acad Sci USA 2005;
102: 142849.
*Alexander M. Seifalian
Centre for Nanotechnology & Regenerative Medicine
University College London
London, UK
Tel: 44 0207 830 2901
Email: a.seifalian@ucl.ac.uk
A review of the QDs and their applications for various biological imaging
Citation: Nano Reviews 2010, 1: 5161 - DOI: 10.3402/nano.v1i0.5161 15
(page number not for citation purpose)